Cargando…

Genome Editing in Patient iPSCs Corrects the Most Prevalent USH2A Mutations and Reveals Intriguing Mutant mRNA Expression Profiles

Inherited retinal dystrophies (IRDs) are characterized by progressive photoreceptor degeneration and vision loss. Usher syndrome (USH) is a syndromic IRD characterized by retinitis pigmentosa (RP) and hearing loss. USH is clinically and genetically heterogeneous, and the most prevalent causative gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanjurjo-Soriano, Carla, Erkilic, Nejla, Baux, David, Mamaeva, Daria, Hamel, Christian P., Meunier, Isabelle, Roux, Anne-Françoise, Kalatzis, Vasiliki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938853/ https://www.ncbi.nlm.nih.gov/pubmed/31909088 http://dx.doi.org/10.1016/j.omtm.2019.11.016

Ejemplares similares

The effect of PTC124 on choroideremia fibroblasts and iPSC-derived RPE raises considerations for therapy
por: Torriano, Simona, et al.
Publicado: (2018)

USH2A variants causing retinitis pigmentosa or Usher syndrome provoke differential retinal phenotypes in disease-specific organoids
por: Sanjurjo-Soriano, Carla, et al.
Publicado: (2023)

Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3
por: Diakatou, Michalitsa, et al.
Publicado: (2021)

A Novel Chromosomal Translocation Identified due to Complex Genetic Instability in iPSC Generated for Choroideremia
por: Erkilic, Nejla, et al.
Publicado: (2019)

Retinoic acid delays initial photoreceptor differentiation and results in a highly structured mature retinal organoid
por: Sanjurjo-Soriano, Carla, et al.
Publicado: (2022)

Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy
por: Sanjurjo-Soriano, Carla, et al.
Publicado: (2018)

Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa
por: Diakatou, Michalitsa, et al.
Publicado: (2019)

The Study of a 231 French Patient Cohort Significantly Extends the Mutational Spectrum of the Two Major Usher Genes MYO7A and USH2A
por: Mansard, Luke, et al.
Publicado: (2021)

Microhomology-assisted scarless genome editing in human iPSCs
por: Kim, Shin-Il, et al.
Publicado: (2018)

Improved and Flexible HDR Editing by Targeting Introns in iPSCs
por: Fu, Juan, et al.
Publicado: (2022)

Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

Modeling Retinitis Pigmentosa: Retinal Organoids Generated From the iPSCs of a Patient With the USH2A Mutation Show Early Developmental Abnormalities
por: Guo, Yonglong, et al.
Publicado: (2019)

Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering
por: Gähwiler, Eric K. N., et al.
Publicado: (2021)

Efficient Precision Genome Editing in iPSCs via Genetic Co-targeting with Selection
por: Mitzelfelt, Katie A., et al.
Publicado: (2017)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
por: Lipus, Alexandra, et al.
Publicado: (2020)

Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015)

Applications of iPSCs in Cancer Research
por: Kim, Jean J
Publicado: (2015)

Reducing genomic instability in iPSCs
por: Ruiz, Sergio, et al.
Publicado: (2015)

The Challenge of Bringing iPSCs to the Patient
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2019)

iPSCs in Modeling and Therapy of Osteoarthritis
por: Csobonyeiova, Maria, et al.
Publicado: (2021)

Versatility of Induced Pluripotent Stem Cells (iPSCs) for Improving the Knowledge on Musculoskeletal Diseases
por: Sanjurjo-Rodríguez, Clara, et al.
Publicado: (2020)

 Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases 
por: Chuang, Katherine, et al.
Publicado: (2017)

iPSCs: From Bench to Clinical Bed
por: Li, Yujing, et al.
Publicado: (2016)

Differentiation of human iPSCs into functional podocytes
por: Rauch, Caroline, et al.
Publicado: (2018)

USH2A Gene Editing Using the CRISPR System
por: Fuster-García, Carla, et al.
Publicado: (2017)

HLA DR Genome Editing with TALENs in Human iPSCs Produced Immune-Tolerant Dendritic Cells
por: Kwon, Yoo-Wook, et al.
Publicado: (2021)

Use of single guided Cas9 nickase to facilitate precise and efficient genome editing in human iPSCs
por: Li, Pan P., et al.
Publicado: (2021)

Functional genomics in stroke: current and future applications of iPSCs and gene editing to dissect the function of risk variants
por: Granata, Alessandra
Publicado: (2023)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
por: Carter, Ava C., et al.
Publicado: (2014)

Disease, iPSCs and a Quest for the Perfect Model
Publicado: (2016)

Clinical Therapy Using iPSCs: Hopes and Challenges
por: Lu, Xiao, et al.
Publicado: (2013)

The Potential of iPSCs for the Treatment of Premature Aging Disorders
por: Compagnucci, Claudia, et al.
Publicado: (2017)

The tale of autologous iPSCs: A monkey perspective
por: Li, Fei
Publicado: (2014)

Tumorigenicity risk of iPSCs in vivo: nip it in the bud
por: Zhong, Chaoliang, et al.
Publicado: (2022)

Functional genomics and the future of iPSCs in disease modeling
por: Brooks, Imogen R., et al.
Publicado: (2022)

Modelling urea cycle disorders using iPSCs
por: Duff, Claire, et al.
Publicado: (2022)

iPSCs in NK Cell Manufacturing and NKEV Development
por: Boyd-Gibbins, Nicholas, et al.
Publicado: (2022)

MSCs vs. iPSCs: Potential in therapeutic applications
por: Thanaskody, Kalaiselvaan, et al.
Publicado: (2022)

Identifying the dynamics of actin and tubulin polymerization in iPSCs and in iPSC-derived neurons
por: Magliocca, Valentina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0eghfe211tsp95kbsp1pi0b3mm